Internal Medicine, Pulmonary Disease · Los Angeles, CA
NPI
1255351854
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
200 Medical Plz, # 365 B
Los Angeles, CA, 90095
Phone (310) 825-6654
Groups this clinician bills Medicare through
Medicare paid, 2024
$148K
1,189 services
Medicare patients, 2024
247
Average age 68
Drug cost, 2024
$8.8M
2,143 prescriptions
Company payments, 2025
$149K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajan Saggar was code 99291 (critical care e&m), 514 times for 104 patients. In total Rajan Saggar billed 1,189 services in 19 codes, and Medicare paid $148K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 514 | 104 | $172.61 | $89K |
| 99233 Hospital E&M - Subsequent | Facility | 323 | 76 | $97.63 | $32K |
| 99214 Office E&M - Established | Facility | 192 | 101 | $74.87 | $14K |
| 99214 Office E&M - Established | Office | 60 | 41 | $102.35 | $6,141 |
| 99215 Office E&M - Established | Facility | 21 | 16 | $105.36 | $2,212 |
| 94618 Pulmonary Function Testing | Facility | 12 | 12 | $15.09 | $181 |
| 31624 Bronchoscopy | Facility | 11 | 11 | $88.81 | $977 |
By year: 2022 $158K for 1,277 services; 2023 $137K for 1,135 services; 2024 $148K for 1,189 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rajan Saggar prescribed most often to Medicare patients was Opsumit (Macitentan), with 240 prescriptions and refills. In total Rajan Saggar wrote 2,143 Medicare prescriptions that cost $8.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 240 | 240 | 28 | $2.9M |
| Tadalafil Generic | 217 | 296 | 33 | $277K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 126 | 274 | 36 | $1,027 |
| Prednisone Generic | 121 | 258 | 29 | $1,080 |
| Orenitram Er Treprostinil Diolamine | 115 | 115 | Under 11 | $1.1M |
| Ambrisentan Generic | 86 | 86 | 11 | $272K |
| Pantoprazole Sodium Generic | 75 | 179 | 21 | $873 |
| Letairis Ambrisentan | 74 | 74 | Under 11 | $957K |
| Posaconazole Generic | 60 | 60 | 11 | $37K |
| Tacrolimus Generic | 58 | 86 | 12 | $9,326 |
| Azithromycin Generic | 53 | 111 | 16 | $411 |
| Adempas Riociguat | 46 | 46 | Under 11 | $611K |
| Furosemide Generic | 44 | 112 | 16 | $339 |
| Acyclovir Generic | 40 | 90 | Under 11 | $754 |
| Tyvaso Dpi Treprostinil | 36 | 36 | Under 11 | $812K |
Brand drugs: - claims; generic drugs: 1,380 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajan Saggar $149K ($149K in general payments such as food, travel and fees) from 8 companies. The largest payer was Merck Sharp & Dohme LLC with $79K.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 65 | $79K |
| United Therapeutics Corporation UTHR | 64 | $53K |
| Insmed, Inc. INSM | 5 | $12K |
| Actelion Pharmaceuticals US, Inc. JNJ | 23 | $3,941 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $436 |
| Liquidia Technologies, Inc. | 6 | $302 |
| Sandoz Inc. SDZ.SW | 21 | $156 |
| Johnson & Johnson Health Care Systems Inc. JNJ | 1 | $20.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.